chrX-19360085-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_001001671.4(MAP3K15):c.*664G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000665 in 169,949 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 44 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001001671.4 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDHA1 | NM_000284.4 | c.*432C>T | 3_prime_UTR_variant | 11/11 | ENST00000422285.7 | ||
MAP3K15 | NM_001001671.4 | c.*664G>A | 3_prime_UTR_variant | 29/29 | ENST00000338883.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP3K15 | ENST00000338883.9 | c.*664G>A | 3_prime_UTR_variant | 29/29 | 5 | NM_001001671.4 | P1 | ||
PDHA1 | ENST00000422285.7 | c.*432C>T | 3_prime_UTR_variant | 11/11 | 1 | NM_000284.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000683 AC: 75AN: 109886Hom.: 0 Cov.: 23 AF XY: 0.000865 AC XY: 28AN XY: 32352
GnomAD4 exome AF: 0.000633 AC: 38AN: 60018Hom.: 0 Cov.: 0 AF XY: 0.00141 AC XY: 16AN XY: 11362
GnomAD4 genome AF: 0.000682 AC: 75AN: 109931Hom.: 0 Cov.: 23 AF XY: 0.000864 AC XY: 28AN XY: 32407
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | MAP3K15: BS2; PDHA1: BS2 - |
Pyruvate dehydrogenase E1-alpha deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at